Impact of Different Embolic Agents for Transarterial Chemoembolization (TACE) Procedures on Systemic Vascular Endothelial Growth Factor (VEGF) Levels

Background and Aims: Intermediate stage hepatocellular carcinoma (HCC) can be treated by transarterial chemoembolization (TACE). However, there appear to be side effects, such as induction of proangiogenic factors, e.g. vascular endothelial growth factor (VEGF), which have been shown to be associate...

Descripción completa

Detalles Bibliográficos
Autores principales: Schicho, Andreas, Hellerbrand, Claus, Krüger, Kristina, Beyer, Lukas P., Wohlgemuth, Walter, Niessen, Christoph, Hohenstein, Ernst, Stroszczynski, Christian, Pereira, Philippe L., Wiggermann, Philipp
Formato: Online Artículo Texto
Lenguaje:English
Publicado: XIA & HE Publishing Inc. 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5225147/
https://www.ncbi.nlm.nih.gov/pubmed/28097096
http://dx.doi.org/10.14218/JCTH.2016.00058

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5225147/
https://www.ncbi.nlm.nih.gov/pubmed/28097096
http://dx.doi.org/10.14218/JCTH.2016.00058

Ejemplares similares